PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF INTESTINAL DISBIOSIS IN PROCESS OF ANTIBACTERIAL THERAPY IN WARM-BLOODED ANIMALS: CATTLE, PIGS, DOMESTIC ANIMALS, IN PARTICULAR DOGS, CATS AND POULTRY AND METHOD OF TREATMENT AND/OR PREVENTION OF INTESTINAL DISBIOSIS IN PROCESS OF ANTIBACTERIAL THERAPY IN WARM-BLOODED ANIMALS: CATTLE, PIGS, DOMESTIC ANIMALS, IN PARTICULAR DOGS, CATS AND POULTRY

摘要

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: pharmaceutical composition contains antimicrobial medication and prebiotic, selected from group, including: disaccharide - lactose or olisaccharide: fructooligosaccaride, maltooligosaccaride, galactooligosaccaride, xilooligosaccaride, isomaltooligosassaride with polymerisation degree from 2 to 15 and with partricle size to 0.5 mm. Antimicrobial medication represents sulfanilamide preparation, selected from group, including: sulfamethazine, sulfadiazine, sulfadimethoxine, sulfamethoxipiridazine, trimethoprim, sulfamethoxazole or antibiotic, selected from group that includes: aminoglycosides, lincosamides, penicillins, polymixines, beta-lactams, including combinations of beta-lactams with inhibitors of bacterial betalactamases; asalides, fluoroquinolines, amphenicoles, glycopeptides, ansamicines, phosphonic acid derivatives or nitrofurane preparation or nitrofuranes, or combination of antibiotic and nitrofurane preparation. Antimicrobial medication and prebiotic are includes into composition formula in weight ratio from 1:1 to 1:120, respectively. ^ EFFECT: invention promotes sanitisation of inflammation focus in the shortest terms at the background of normalisation of intestinal microflora in quantitative and qualitative respect due to stimulation of growth and reproduction of intestinal lactobaccili and bifidobacteria. ^ 4 cl, 9 ex